Speech Pathology Australia 2022 Annual Report

Statement of changes in equity For the year ended 31 December 2022

Notes

Retained equity $

Total equity $

Balance at 1 January 2022 Net surplus/(deficit) for the year Other comprehensive income Balance at 31 December 2022 Net surplus/(deficit) for the year Other comprehensive income Total comprehensive income for the year Total comprehensive income for the year

3,234,276

3,234,276

319,294

319,294

-

-

319,294

319,294

3,553,570 (591,263)

3,553,570 (591,263)

-

-

(591,263) 2,962,307

(591,263) 2,962,307

Balance at 31 December 2022

This statement should be read in conjunction with the notes to the financial statements. Statement of cash flows For the year ended 31 December 2022

Notes

2022 $

2021 $

OPERATING SERVICES Receipts from Member Services

8,353,925 (8,851,516)

8,079,057 (7,047,013)

Payments to members, suppliers and employees

Income tax paid Interest received

(5,612) 32,879 (1,187)

(21,925)

3,636

(17,715) 996,040

Interest paid

Net cash provided by operating activities

(471,511)

18

INVESTING ACTIVITIES Proceeds from redemption of/(payment for) financial assets

82,381

(1,876,053) (168,786)

Purchase of property, plant and equipment Proceeds from property, plant & equipment

(41,601)

0

0

Net cash provided by / (used in) investing activities

40,780

(2,044,839)

FINANCING ACTIVITIES Repayment of lease liability

(313,060) (313,060) (743,791) 3,220,198 2,476,407

(289,570) (289,570) (1,338,369) 4,558,567 3,220,198

Net cash provided by / (used in) financing activities

Net change in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year

7

This statement should be read in conjunction with the notes to the financial statements.

13 2022 ANNUAL REPORT Speech Pathology Australia